The Scope of Things
The Scope of Things
Latest Episodes
Episode: 53 - Daphne Smyth on the Chinese Drug Development Market Expansion
With increasing efforts to scale into international markets, what can we expect from China's drug development industry? Joining the podcast is Daphne Smyth, head of global regulatory programs at Veristat, who shares her experience at this year'...
Episode: 52 - Raj Indupuri on Adoption Hurdles with AI Agents
Clinical trial support companies are rapidly adopting AI, but sponsors have been more hesitant. Raj Indupuri, CEO of eClinical Solutions, gives the top three reasons behind the holdup in AI agent deployment. He explains the specific pattern of ...
Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Are medical advancements closing or widening medical disparities? Eugene Manley, Jr., Ph.D., founder and CEO of the STEMM & Cancer Health Equity Foundation, breaks down why equity is still not completely measurable in clinical trials, what ...
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Health equity is being reorganized, renamed, or quietly deprioritized. Ramona Burress, co-founder of Onyx Health Collective, and Cassandra O’Neal, founder of Illuminated Arc Consulting, join the Scope of Things podcast for a direct, practical c...
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
What will AI and clinical trials look like in the year 2030? Mike Sullivan, head of IT globally for development operations at Bristol Myers Squibb, joins The Scope of Things to discuss how creating value with AI depends on redesigning how clini...
